Pindolol

Chemical formula: C₁₄H₂₀N₂O₂  Molecular mass: 248.321 g/mol  PubChem compound: 4828

Therapeutic indications

Pindolol is indicated for:

Essential hypertension

Population group: only adults (18 years old or older)

For reduction of blood pressure in essential hypertension. Onset of action of Pindolol is usually rapid, most patients showing a response within the first one to two weeks of treatment. However, maximum response may take several weeks to develop.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylactic treatment of angina pectoris

Population group: only adults (18 years old or older)

Prophylactic treatment with pindolol reduces the frequency and severity of anginal attacks and increases work capacity.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Pindolol is contraindicated in the following cases:

Hypersensitivity to pindolol

Pindolol allergy

Untreated cardiac failure

Cardiac failure

Atrioventricular block

AVB - Atrioventricular block

Cardiogenic shock

Cardiogenic shock

Bradycardia

Bradycardia

Second and third degree heart block

at least one of
Second degree atrioventricular block
Complete atrioventricular block

Obstructive pulmonary disease

Chronic obstructive lung disease

Bronchial asthma

Airway hyperreactivity

Bronchospasm

Bronchospasm

Cor pulmonale

Cor pulmonale

Metabolic acidosis

Metabolic acidosis

Prolonged fasting

Fasting

Severe renal failure

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Sick sinus syndrome

Sick sinus syndrome

Prinzmetal angina

Prinzmetal angina

Untreated phaeochromocytoma

Phaeochromocytoma

Peripheral circulatory disturbances

Poor peripheral circulation

Calcium channel blockers

Calcium channel blockers

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2014: PINDOLOL Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈